Dr Nason Maani
BSc MPH PhD FRSA
Public Health Evaluation
15-17 Tavistock Place
I am a public health researcher focused on the structural and commercial determinants of health. I also serve as advisor to the Boston University/Rockefeller 3D commission on Data, Determinants and Decision-making.
I was a 2019-2020 Commonwealth Fund Harkness Fellowship at Boston University School of Public Health, working with Sandro Galea on the structural drivers of vulnerability to COVID-19 in the US.
I have a degree in Biomedical Science and a diploma in professional practice as a hospital biomedical scientist, a PhD in biochemistry focusing on the design and characteristics of DNA quadruplexes, and worked in medical communications before a career change into public health, facilitated by an MSc in Public Health at LSHTM.
I am also interested in transparency and accountability in public spending, and served from 2016-2019 as a Patient and Public Voice Member of NHS England's Clinical Priorities Advisory Group (CPAG)
I am a member of the UK Society for Social Medicine and the European Public Health Association, a fellow of the Royal Society of Arts, and an associate fellow of the Higher Education Academy.
I am a module co-organiser on the Issues in Public Health module (a module I once took as a a student on the LSHTM MSc as part of a career change into public health research!)
I am also a postgraduate tutor on the MSc Public Health programme and supervisor MSc final year projects.
My research seeks to describe how commercial and structural determinants affect the generation of knowledge, public discourse, health and health equity. My academic work has been published in journals such as the Journal of Epidemiology and Community Health, JAMA, the Milbank Quarterly and the BMJ, and covered by new outlets including CNN, Reuters, the Guardian, the Telegraph and the Sydney Morning Herald. I recently co-authored a commentary in Lancet Public Health entitled “Corporate Practices and the Health of Populations: A research and translational agenda” that points to possible ways in which to advance this field of study.
Recent academic papers:
N. Maani, S. Abdalla, S. Galea. The Firearms Industry as a Commercial Determinant of Health. American Journal of Public Health. 2020.
N. Maani, S. Galea. COVID‐19 and Underinvestment in the Public Health Infrastructure of the United States. The Milbank Quarterly. 2020.
N. Maani, S. Galea. COVID‐19 and Underinvestment in the Health of the US Population. The Milbank Quarterly. 2020.
N. Maani, S. Galea. The Role of Physicians in Addressing Social Determinants of Health. JAMA Viewpoint. 2020.
N. Maani, M. McKee, M. Petticrew, S. Galea. Corporate practices and the health of populations: a research and translational agenda. Lancet Public Health. 2020.
N. Maani, J. Collin, S. Friel, A.B. Gilmore, J. McCambridge, L. Robertson, M. Petticrew. Bringing the commercial determinants of health out of the shadows: a review of how the commercial determinants are represented in conceptual frameworks. Eur J Public Health. 2020.
N. Maani, A. Bertscher, N. Critchlow, N. Fitzgerald, C. Knai, M. Stead, M. Petticrew. Recruiting the "Heavy-Using Loyalists of Tomorrow": An Analysis of the Aims, Effects and Mechanisms of Alcohol Advertising based on Advertising Industry Evaluations." IJERPH 2019.
Recent public writing:
N. Maani, S. Galea. "How American Health was Broken Before COVID-19". Psychology Today. 2020.
S. Galea, N. Maani. "The Non-immigrant Visa Proclamation is the Latest Step Toward Self-destructive Othering." The Hill. 2020.
N. Maani, S. Galea. "The True Costs of the COVID-19 Pandemic." Scientific American 2020.
N. Maani. "Compassion Is the Sixth Sense Humanity Needs." Thrive Global. 2020.
N. Maani. "Out of the shadows: Corporate activity and our health." The FUSE Centre for Translational Research. 2020.
N.Maani. "The commercial determinants of health: A challenge for the Transforming Evidence Community". Transforming Evidence Community Blog. 2020.
N. Maani, G. Ruskin, M McKee, D Stuckler. Public meets Private: Conversations between Coca-Cola and the CDC. Milbank Quarterly. 2019.